DigiBiomics Inc. is a health-tech company located in Mississauga, Canada. The company specializes in using AI and advanced data analytics to enhance healthcare, focusing on early diagnosis and personalized treatment. Their flagship product, PulmoDeep, is an AI-powered diagnostic tool that detects lung diseases by analyzing clinical and imaging data, offering precise diagnostic insights and triage recommendations.

In addition to diagnostics, DigiBiomics is involved in cancer screening and drug discovery, utilizing AI and machine learning to improve detection strategies and facilitate the development of new treatments. They also create predictive health models to better anticipate and manage health risks. The company employs advanced technologies, including AI, machine learning, and blockchain, to optimize medical data analysis and provide evidence-based precision diagnoses.